KR102258773B1 - An animal feed form with poultry productivity improvement - Google Patents
An animal feed form with poultry productivity improvement Download PDFInfo
- Publication number
- KR102258773B1 KR102258773B1 KR1020190072885A KR20190072885A KR102258773B1 KR 102258773 B1 KR102258773 B1 KR 102258773B1 KR 1020190072885 A KR1020190072885 A KR 1020190072885A KR 20190072885 A KR20190072885 A KR 20190072885A KR 102258773 B1 KR102258773 B1 KR 102258773B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mugwort
- delete delete
- propanol
- feed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Fodder In General (AREA)
Abstract
본 발명은, 가금류 생산성 향상을 위한 동물사료에 관한 것이다.The present invention relates to animal feed for improving poultry productivity.
Description
본 발명은 쑥 추출물을 이용한 사료 조성물의 가금류 생산성 개선효과에 관한 것이다.The present invention relates to the effect of improving the poultry productivity of a feed composition using mugwort extract.
종래 가축의 생산성 개선을 위해서는 사료첨가제(생균제 등), 성장촉진용 항생제등 장 발달 촉진을 위한 다양한 첨가제 급이가 지속적으로 이루어져 왔다. 특히 성장촉진용 항생제는 장관 미생물 균총 조정을 통해 비타민 합성을 촉진하며 위장관 점막 개선을 통해 영양소 이용률을 증가(Groschke, 1950; Thayer 등, 1950)시킨다. 또한, 위장관 내 미생물의 서식 및 증식을 억제하여 사료 내 영양소 이용률을 개선(Dibner와 Richards, 2005)시키며 괴사성장염의 원인균인 Clostridium perfringens의 증식을 억제하여 장내 염증유발을 억제한다(Lev와 Forbs, 1959). 아울러 미생물의 Urease 억제로 소장 점막 손상, 영양소 흡수 이상, 성장 지연 등을 감소시키며 소장 점막세포 및 융모의 분화 촉진을 통한 영양소 흡수율을 증가시키는 등 여러 효능이 밝혀져 있어(Parker, 1990) 가장 보편적으로 사용되어 왔다. In order to improve the productivity of livestock in the prior art, various additives for promoting intestinal development such as feed additives (probiotics, etc.) and antibiotics for promoting growth have been continuously fed. In particular, growth-promoting antibiotics promote vitamin synthesis by adjusting the intestinal microflora and increase nutrient utilization by improving the gastrointestinal mucosa (Groschke, 1950; Thayer et al., 1950). In addition, it inhibits the colonization and proliferation of microorganisms in the gastrointestinal tract to improve the utilization of nutrients in feed (Dibner and Richards, 2005), and suppresses the proliferation of Clostridium perfringens , the causative agent of necrotizing enterocolitis, to suppress the induction of intestinal inflammation (Lev and Forbs, 1959). ). In addition, various effects such as reducing intestinal mucosa damage, abnormal nutrient absorption, growth retardation, etc. by inhibiting microbial urease, and increasing the nutrient absorption rate by promoting the differentiation of small intestine mucosal cells and villi (Parker, 1990), are the most commonly used. has been
대한민국 등록특허 1994-0000065호에서는 항생제를 동물사료에 이용 시 가축류 건강증진과 체중증가에 대한 효과를 공개하고 있다. 대한민국 등록특허 특1995-0009944호에서는 전염병 예방과 치료 및 육용동물의 체중증가를 위해 겐타마이신과 린코마이신 또는 클린다마이신의 항생제 혼합물을 함유한 동물사료 또는 음료수 첨가제를 개시하였다. 대한민국 등록특허 921620호에서는 야콘노두, 야콘 잎, 야콘 줄기, 유황 및 황토분말을 포함하는 성장촉진용 동물용 사료 첨가제를 청구하고 있다. 대한민국 등록특허 906838호에서는 동물용 효소용액을 이용하여 펠렛화 한 동물사료 제조방법을 청구하고 있다. 대한민국 등록특허 1008463호에서는 항균 및 항바이러스 활성을 갖는 오배자 추출물을 이용하여 돼지의 소화기 질환예방 및 치료용 수의학적 조성물을 개시하고 있다. Republic of Korea Patent No. 1994-0000065 discloses the effect of using antibiotics in animal feed on livestock health promotion and weight gain. Korean Patent No. 1995-0009944 discloses an animal feed or beverage additive containing an antibiotic mixture of gentamicin, lincomycin or clindamycin for prevention and treatment of infectious diseases and weight gain of carnivores. Republic of Korea Patent Registration No. 921620 claims a feed additive for animals for growth promotion, including yacon outcrops, yacon leaves, yacon stems, sulfur and loess powder. Korean Patent No. 906838 claims a method for producing pelletized animal feed using an enzyme solution for animals. Republic of Korea Patent No. 1008463 discloses a veterinary composition for preventing and treating digestive diseases of pigs using an extract of baeja baeja having antibacterial and antiviral activity.
세균성 질환의 치료에 사용되는 항생제의 경우 동물에 사용할 경우 상처의 치유속도가 빠르고 가격이 저렴하며 성장을 촉진시키는 등의 장점이 존재한다. In the case of antibiotics used for the treatment of bacterial diseases, when used in animals, the wound healing speed is fast, the price is low, and there are advantages such as promoting growth.
그러나, 한국수의과학검역원이 2001~2004년 발표한 ‘연도별 항생제 판매실적’과 외국자료를 분석한 자료에 ‘우리나라 축수산업의 항생제 오남용 실태 정책보고서’에서 “우리나라 축수산업의 항생제 사용량이 연간 1천500톤으로 축산품 생산량이 우리의 1.2배인 덴마크 사용량(연간 94톤)의 16배”이며 이 수치는 “우리나라의 생산량 대비 항생제 사용량이 세계 최고 수준” 이라고 주장하였다. 실제로 가축별로 2001~2003년 평균 돼지 (87만1천741kg), 닭(35만975kg), 수산물(19만2천699kg), 소(10만9천500kg)의 순으로 항생제가 사용되었다고 한다. However, according to the 'Antibiotic Sales Performance by Year' published by the Korea Veterinary Science and Quarantine Service from 2001 to 2004 and the data analyzing foreign data, in the 'Policy Report on the Misuse and Abuse of Antibiotics in Korea's Livestock Industry', 1,500 tons of livestock production is 16 times that of Denmark (94 tons per year), which is 1.2 times our livestock production.” This figure claimed that “Korea’s use of antibiotics relative to production is the highest in the world”. In fact, according to livestock, the average number of antibiotics used from 2001 to 2003 was pigs (871,741 kg), chickens (359,75 kg), aquatic products (192,699 kg), and cattle (109,500 kg).
이러한 항생제의 사용이 초기에는 큰 문제가 없다고 하더라도 지속적으로 사용하게 될 경우 면역반응에 의한 내성이 생기는 문제가 존재한다. 즉, 이로 인하여 추후에는 더 많은 양이 사용되어야지만 그 약효를 발휘하게 되는 문제점이 존재한다. 또한, 사람의 경우 한 번도 항생제를 복용하지 않은 사람이라고 하더라도 항생제를 먹으며 자란 식용 육류를 섭취하게 될 경우 결국 동일한 문제점이 발생될 것이라는 것을 쉽게 생각할 수 있다. Even if the use of these antibiotics is not a big problem in the beginning, there is a problem that resistance occurs due to an immune response if it is continuously used. That is, due to this, there is a problem in that a larger amount must be used in the future, but the medicinal effect is exerted. In addition, in the case of humans, even if they have never taken antibiotics, it is easy to think that the same problem will eventually occur if they eat meat grown while eating antibiotics.
이러한 문제를 해결하기 위하여 정부는 배합사료 내 사용량을 규제 하였으며 이에 따라 가축의 생산성 저하(사료섭취량 저하, 폐사율 증가, 계군 균일도 저하, 증체량 감소, 사료 효율 저하) 및 환경오염 증가, 질병 발생률 증가 등이 예상되며 경제적인 측면에서도 항생제 사용규제에 따라 연간 1조원이상의 생산비용이 증가할 것으로 예상되고 있는 상황이다(동물약품협회, 2010). 특히, 양계의 경우 소화기질병인 괴사성장염 (웰치균에 의한 세균성 질병으로 장에 괴사를 일으키며 증체율 감소, 페사율 증가 등에 피해), 콕시듐증 (기생충성 원충인 Eimeria속 콕시디아 원충이 닭의 장관에 기생하여 설사, 혈변, 장기조직의 출혈 등을 나타내는 질병으로 장세포 내에 증식, 장점막 및 점막하 조직에 침입하여 이들 조직을 파괴), 암모니아중독 (축사내 암모니아 증가로 인한 소화기 전체 장점막세포 손상)등의 문제가 발생될 수 있다. 이러한 결과들로 인해 폐사율 증가와 육계의 더딘 성장은 결국 생산성 저하로 이어져 가축농가의 피해가 더욱 커지고 있는 실정이다. 이에, 항생제 사용량 규제에 따라서 발생되는 동물의 질병 증가에 대한 문제 해결을 위해서 다양한 접근방법들이 연구되어 왔다.In order to solve this problem, the government regulated the amount of use in compounded feed. As a result, the productivity of livestock decreased (feed intake decreased, mortality increased, flock uniformity decreased, weight gain decreased, feed efficiency decreased), environmental pollution increased, and disease incidence increased. From an economic standpoint, the production cost is expected to increase by more than KRW 1 trillion per year due to regulations on the use of antibiotics (Veterinary Medicine Association, 2010). In particular, in the case of poultry, necrotizing enterocolitis (a bacterial disease caused by Welch bacteria, which causes necrosis in the intestines and damages the decrease in growth rate and increase in pessa rates), coccidiosis (parasitic protozoa, Eimeria genus Coccidia protozoa, parasitizes in the intestinal tract of chickens) This is a disease that causes diarrhea, bloody stool, and bleeding from organ tissues. It proliferates in intestinal cells, invades intestinal mucosa and submucosa and destroys these tissues), ammonia poisoning (damage to intestinal mucosa cells throughout the digestive tract due to increased ammonia in livestock) may occur. Due to these results, the increase in mortality rate and the slow growth of broilers eventually lead to a decrease in productivity, which further increases the damage to livestock farms. Accordingly, various approaches have been studied in order to solve the problem of increasing animal diseases caused by the regulation of the use of antibiotics.
예를들면, 대한민국 등록특허 877800호에서는 대잎이나 대숯을 포함하여 사료효율을 향상시키고 육질개선 및 증체량 증가에 대한 연구를 진행하였으며 항산화 활성을 갖는 적송(red pine tree)의 잎이나 추출물을 이용하여 대한민국 등록특허 804722호에서는 사육기간단축, 사료비 절감 및 면역력 증대를 통해 가축농가의 소득증대에 기여하고자 하였다. 이와 유사하게 대한민국 등록특허 777833호에서는 오미자 추출물, 대한민국 등록특허 881033호에서는 맨드라미 추출물을 이용하였으며 대한민국 등록특허 406158호에서는 약모밀, 이질풀, 새삼, 인동덩굴, 결명차, 감초, 꼭두서니와 같은 천연 생약제의 추출물을 이용하여 독성을 제거하여 항염증 효과를 동물에서도 얻을 수 있다는 것을 보고하였다. 그러나, 지금까지 보고된 선행문헌은, 천연 생약제에 별다른 가공을 행하지 않고 건조하여 그대로 사료에 투입하거나 또는 복수의 천연 생약제를 간단한 조작을 거쳐 다량으로 사료에 첨가하는 것에 불과했으며, 동물성장을 촉진하거나 증체량을 증가시키기 위해서 추출물중에 존재하는 개별성분별 접근은 행해진 바 없고, 특히, 사료중에 배합되는 동물사료첨가제의 양을 극히 적게 유지하면서도 원하는 목적을 달성하는 수단에 대해서는 개시한 바 없다.For example, in Korean Patent Registration No. 877800, a study was conducted on improving feed efficiency, improving meat quality and increasing weight by including bamboo leaves or bamboo charcoal, and using leaves or extracts of red pine trees with antioxidant activity in the Republic of Korea In Patent Registration No. 804722, it was intended to contribute to the increase of the income of livestock farmers by shortening the breeding period, reducing feed cost, and increasing immunity. Similarly, Korean Patent Registration No. 777833 uses Schisandra extract, Korean Patent No. 881033 uses cockscomb extract, and Korean Patent Registration No. 406158 uses extracts of natural herbal medicines such as honeysuckle, honeysuckle, red ginseng, honeysuckle, Gyunmyung tea, licorice, and horseradish. It has been reported that the anti-inflammatory effect can be obtained even in animals by removing the toxicity. However, the prior literature reported so far is nothing more than adding a large amount of natural herbal medicines to the feed without any special processing, either by drying them and adding them to the feed as it is, or by adding a plurality of natural herbal medicines to the feed through a simple operation, promoting animal growth or In order to increase the weight gain, an approach for each individual component present in the extract has not been performed, and in particular, there is no disclosure of a means for achieving the desired purpose while keeping the amount of the animal feed additive blended in the feed extremely small.
이에 본 발명자들은, 동물의 성장을 촉진시키고, 가축의 폐사율을 줄이고, 생산성을 증가시킬 수 있으며 항생제가 배합된 동물사료를 대체할 수 있는, 이제까지 보고되지 않았던 신규의 동물사료용 첨가제를 예의 연구하여 본 발명에 이르렀다.Accordingly, the present inventors have researched a novel additive for animal feed that has not been reported before, which can promote the growth of animals, reduce the mortality rate of livestock, increase productivity, and replace the animal feed formulated with antibiotics. came to the invention.
이를 위하여 본 발명에서는 쑥 추출물을 포함하는 동물성장촉진용 사료조성물이 제공된다.To this end, in the present invention, there is provided a feed composition for promoting animal growth comprising a mugwort extract.
또한, 본 발명의 사료조성물에 있어서, 상기 쑥 추출물은 에탄올, 1-프로판올, 2-프로판올, 2-부탄올, 1-부탄올 또는 2-메칠-1프로판올을 포함하는 C1~6 알코올을 이용하여 추출된 것을 특징으로 하는 사료조성물이 제공된다.In addition, in the feed composition of the present invention, the mugwort extract is extracted using C1-6 alcohol including ethanol, 1-propanol, 2-propanol, 2-butanol, 1-butanol or 2-methyl-1propanol. There is provided a feed composition, characterized in that.
나아가, 본 발명의 사료조성물에 있어서, 쑥은 황해쑥(Artemisia argyi), 쑥(A. princeps var. orientalis, Al asiatica), 산쑥(A. montana), 참쑥(A. mongolica) 및 대한약전외 한약(생약)규격집에 정의된 동속식물로부터 선택되는 것을 특징으로 하는 사료조성물이 제공된다.Furthermore, in the feed composition of the present invention, mugwort is yellow sea mugwort (Artemisia argyi), mugwort (A. princeps var. orientalis, Al asiatica), wild mugwort (A. montana), wormwood (A. mongolica) and Korean herbal medicines outside the Korean Pharmacopoeia. A feed composition is provided, characterized in that it is selected from plants and animals defined in the (crude drug) standard.
또한, 본 발명의 사료조성물에 있어서, 쑥을 추출시 침지법, 환류법, 냉침 또는 초음파 방법으로 추출하는 것을 특징으로 하는 사료조성물이 제공된다.In addition, in the feed composition of the present invention, there is provided a feed composition characterized in that the mugwort is extracted by an immersion method, a reflux method, an ice-chilling method, or an ultrasonic method.
또한, 본 발명의 사료조성물을 제조하는 방법으로서, 쑥 추출물을 여과, 농축하는 공정을 포함하여 얻은 연조엑스와 동물사료를 혼합하여 제조하는 것을 특징으로 하는 제 1항의 사료조성물의 제조방법이 제공된다.In addition, there is provided a method for producing the feed composition of claim 1, wherein the method for producing the feed composition of the present invention comprises mixing the soft algae extract obtained including the process of filtering and concentrating the mugwort extract and animal feed. .
또 다른 본 발명의 특징으로서, 본 발명에서는, 쑥을 저급알코올로 추출해서 얻어지는 유파틸린 및 자세오시딘을 포함하는 쑥 추출물을 투여하는 것을 특징으로 하는 동물성장촉진방법이 제공된다.As another feature of the present invention, there is provided a method for promoting animal growth, comprising administering a mugwort extract containing eupatylin and zeosidine obtained by extracting mugwort with lower alcohol.
또한, 상기 동물성장촉진방법에 있어서, 상기 저급알코올은 C1~6 알코올인 것을 특징으로 하는 동물성장촉진방법이 제공된다.In addition, in the animal growth promotion method, the lower alcohol is a C1-6 alcohol is provided, characterized in that the animal growth promotion method.
나아가, 상기 동물성장촉진방법에 있어서, 상기 쑥 추출물의 투여량은 동물 1kg당 0.3mg 이하인 것을 특징으로 하는 동물성장촉진방법이 제공된다.Furthermore, in the method for promoting animal growth, there is provided a method for promoting animal growth, characterized in that the dosage of the mugwort extract is 0.3 mg per kg of animal or less.
이하, 본 발명의 첫 번째 특징인 쑥추출물을 포함하는 동물성장촉진용 사료조성물에 대해서 설명한다.Hereinafter, a feed composition for promoting animal growth comprising mugwort extract, which is the first feature of the present invention, will be described.
본 발명에서 이용한 쑥은 황해쑥(Artemisia argyi), 쑥(A. princeps var. orientalis, A. asiatica), 산쑥(A. montana), 참쑥(A. mongolica) 및 대한약전외 한약(생약)규격집에 정의된 동종식물을 포함한다. 쑥은 한방에서 애엽이라 지칭되며, 소염, 해열, 지혈, 이뇨등의 작용이 있다고 알려져 있다. 한편, 쑥은, 인체투약을 목적으로 한 의약품으로도 시판되고 있는데, 예를들면, 애엽추출물을 포함하는 스티렌정이 있을 수 있다. 이 외에도 약용식물을 이용한 인체투약용 의약품은 추나약물을 포함하는 신바로캡슐, 위령선, 괄루근 하고초를 포함하는 조인스정, 상황균사체엑스를 포함한 메시마엑스산 등을 들 수 있다. 그러나, 쑥 추출물을 인체에 투여했을 때 위장보호를 통한 위점막보호효과가 있다는 사실은 보고되었으나, 쑥 추출물을 사료에 배합하여 동물에 투여했을 때 어떤 효과가 나타나는지에 대해서는 알려진 바 없으며, 특히, 쑥 추출물과 동물성장촉진 및 폐사율감소와 어떠한 상관관계가 있는지에 대해서는 보고된 바 없다. 이에 본 발명자들은 항생제 대체물질로서 다양한 약용식물을 이용하는 방법을 연구하던 중, 쑥 추출물을 매우 소량으로 사료에 배합한 때에 폐사율을 줄이고 높은 생산지수를 보이는 것에 착안하여 본 발명에 이르게 되었다. 즉, 본 발명에서는, 쑥 추출물의 투여량을, 1일 복용량으로서 체중 kg당 0.3mg이하로 설정하고 있는데, 이는, 스티렌에서 이용한 애엽추출물에서 유효량으로 설정한 kg당 3mg의 10% 이하에 해당한다. 그런데, 식품의약품안전청고시 의약품의 품목허가, 신고, 심사규정(제2010-103호, 2010.12.31) 제12조 제5항 제2호에서 약리작용이 있는 것으로 확인된 성분을 1일 최저 상용량의 1/5 이하를 사용하는 경우는 유효성분이 아닌 다른 목적의 첨가제로서 이용이 가능하다고 규정하고 있으며, 이러한 사실은 임상시험 등을 통해 밝혀진 최소 유효성분량의 20% 이하로 사용하였을 경우에는 통상적으로 약효를 기대하기 어렵다는 것을 나타낸다. 그러나 본 발명에서 이용한 쑥추출물의 양은 스티렌정 허가량 kg당 3mg의 10%이하인 kg당 0.3mg이하의 양을 동물 사료에 포함시켜 급이하였음에도 불구하고 유효한 동물의 체중증가효과, 폐사율감소 및 생산지수 증가와 같은 예상하지 못한 결과를 얻게 되어 본 발명에 이르게 되었다. Mugwort used in the present invention is yellow sea mugwort (Artemisia argyi), mugwort (A. princeps var. orientalis, A. asiatica), wild mugwort (A. montana), wormwood (A. mongolica), and Korean herbal medicine (crude medicine) standards outside the Korean Pharmacopoeia. Includes defined allografts. Mugwort is called ayeop in oriental medicine and is known to have anti-inflammatory, antipyretic, hemostasis, and diuretic effects. On the other hand, mugwort is also marketed as a drug intended for human administration, for example, there may be a styrene tablet containing a leaf extract. In addition to this, medicines for human administration using medicinal plants include Shinbaro capsule containing Chuna drug, Wiryongseon, Joins tablet containing Gwalugeun Hagocho, and Mesima EX acid containing Sanghwang mycelium body extract. However, it has been reported that when mugwort extract is administered to the human body, there is a gastric mucosal protective effect through gastrointestinal protection, but it is not known what effect appears when the mugwort extract is formulated in feed and administered to animals. It has not been reported on any correlation between the extract and animal growth promotion and mortality reduction. Accordingly, the present inventors came to the present invention by focusing on reducing the mortality rate and showing a high production index when a very small amount of mugwort extract was formulated in feed while researching a method of using various medicinal plants as an alternative to antibiotics. That is, in the present invention, the dosage of mugwort extract is set to be 0.3 mg per kg of body weight or less as a daily dose, which corresponds to 10% or less of 3 mg per kg set as an effective amount in the aebyeop extract used in styrene. . However, the ingredients confirmed to have pharmacological action in Article 12 (5) No. 2 of the Regulations on Approval, Reporting, and Review of Drugs (No. 2010-103, December 31, 2010) as notified by the Korea Food and Drug Administration should be used at the lowest daily dose. In the case of using less than 1/5, it is stipulated that it can be used as an additive for purposes other than the active ingredient. It indicates that it is difficult to expect. However, despite the fact that the amount of mugwort extract used in the present invention was 0.3 mg per kg or less, which is 10% or less of 3 mg per kg of the permitted amount of styrene tablets, included in the animal feed, effective animal weight gain effect, mortality rate reduction, and production index increase Such unexpected results were obtained, leading to the present invention.
본 발명의 쑥 추출물을 제조하기 위해서는 저급알코올을 사용할 수 있으며, 탄소수 C1~6의 저급알코올을 사용하는 것이 바람직하다. 상기 용매의 구체적인 예에는, 에탄올, n-프로판올, 이소프로판올, 탄소수 4의 알콜류 즉, 2-부탄올, 1-부탄올, 2-메칠-1-프로판올이 포함될 수 있다. 본 발명에서는, 쑥을 저급알코올로 추출한 연조엑스를 이용할 수 있으며, 이 경우, 연조엑스 1g은 쑥 약 20g에 해당하도록 조정할 수 있다.In order to prepare the mugwort extract of the present invention, a lower alcohol may be used, and it is preferable to use a lower alcohol having C1 to C6 carbon atoms. Specific examples of the solvent may include ethanol, n-propanol, isopropanol, and alcohols having 4 carbon atoms, that is, 2-butanol, 1-butanol, and 2-methyl-1-propanol. In the present invention, it is possible to use a soft extract extracted from mugwort with lower alcohol, and in this case, 1 g of the soft extract can be adjusted to correspond to about 20 g of mugwort.
본 발명에서 쑥을 저급알코올로 추출하였을 때에는, 유파틸린, 자세오시딘이 고농도로 추출되게 된다. 구체적으로는, 본 발명의 추출법에 의해서 쑥 추출물을 제조하는 경우, 쑥 추출물은 유파틸린을 0.80~2.40중량%로 함유할 수 있고, 자세오시딘을 0.25~0.75중량%로 함유할 수 있다. 본 발명에서는, 위와 같이 쑥을 저급알코올로 추출하여 얻어진 유파틸린 및 자세오시딘이 포함되어 있는 쑥 추출물을 동물사료에 배합하여 동물의 성장을 촉진시키고, 폐사율감소의 효과를 얻을 수 있다. 유파틸린과 자세오시딘은 인체에 투여하였을 때 위점막보호효과를 가진다고 알려져 있지만, 본 발명에서는, 이를 극히 소량으로 동물에 투여함으로써 동물의 성장을 촉진하고 및 폐사율을 감소시킨다는 새로운 용도를 개시한다. 또한, 쑥 추출물을 투여하는 것과 아울러, 본 발명의 기술사상에는, 쑥으로부터 저급 알코올을 이용하여 추출한 유파틸린 및/또는 자세오시딘을 동물에 투여하여 동물의 성장을 촉진시키는 방법도 포함된다. In the present invention, when mugwort is extracted with lower alcohol, eupatylin and zagiosidine are extracted at high concentrations. Specifically, when the mugwort extract is prepared by the extraction method of the present invention, the mugwort extract may contain eupatylin in an amount of 0.80 to 2.40% by weight and zagiosidine in an amount of 0.25 to 0.75% by weight. In the present invention, the mugwort extract containing eupatylin and azaosidine obtained by extracting mugwort with lower alcohol as described above can be blended with animal feed to promote animal growth and reduce mortality. Eupatylline and zeosidine are known to have a gastric mucosal protective effect when administered to the human body, but in the present invention, a novel use of promoting the growth of animals and reducing mortality by administering them to animals in very small amounts is disclosed. In addition to administering the mugwort extract, the technical idea of the present invention includes a method of promoting the growth of the animal by administering to the animal eupatylin and/or zeosidine extracted from mugwort using a lower alcohol.
본 발명에서 이용한 추출방법으로는 통상의 생약추출법 즉, 침지법, 환류법, 냉침 또는 초음파 방법을 이용할 수 있다. As the extraction method used in the present invention, a conventional herbal extraction method, that is, an immersion method, a reflux method, a cold acupuncture method, or an ultrasonic method may be used.
가축의 폐사율을 줄이고 생산성을 개선하여 항생제가 배합된 동물사료를 대체할 수 있는 동물사료용 첨가제를 제공한다.To provide an additive for animal feed that can replace animal feed containing antibiotics by reducing the mortality rate of livestock and improving productivity.
실시예1-1> 쑥추출물 제조Example 1-1> Preparation of mugwort extract
쑥(A. princeps var. orientalis, A. asiatica) 1Kg을 1-프로판올 10Kg에 가하여(중량비 1:10) 추출 후 잔류물에 추가로 1-프로판올을 가하여 재추출 한다. 그 후, 추출액을 여과하여 65도 이하에서 감압농축하여 연조엑스 약 50g을 제조하였다. 제조한 연조엑스 50g을 취하여 액체크로마토그래피법을 사용하여 정량하여 유파틸린이 1.4중량%, 자세오시딘이 0.63중량%임을 확인하였다.Add 1 kg of mugwort (A. princeps var. orientalis, A. asiatica) to 10 kg of 1-propanol (weight ratio 1:10) and then re-extract by adding 1-propanol to the residue. Thereafter, the extract was filtered and concentrated under reduced pressure at 65 degrees or less to prepare about 50 g of soft extract. 50 g of the prepared soft extract was quantified using liquid chromatography, and it was confirmed that upatilin was 1.4% by weight and zeosidine was 0.63% by weight.
<실시예1-2> 쑥추출물 제조<Example 1-2> Preparation of mugwort extract
쑥(A. princeps var. orientalis, A. asiatica) 1Kg을 2-프로판올 13Kg에 가하여(중량비 1:13) 추출 후 잔류물에 추가로 2-프로판올을 가하여 재추출 한다. 그 후, 추출액을 여과하여 65도 이하에서 감압농축하여 연조엑스 약 50g을 제조하였다. 제조한 연조엑스 50g을 취하여 액체크로마토그래피법을 사용하여 정량하여 유파틸린이 1.6중량%, 자세오시딘이 0.68중량%임을 확인하였다. 1Kg of mugwort (A. princeps var. orientalis, A. asiatica) was added to 13Kg of 2-propanol (weight ratio 1:13), followed by re-extraction by adding 2-propanol to the residue. Thereafter, the extract was filtered and concentrated under reduced pressure at 65 degrees or less to prepare about 50 g of soft extract. 50 g of the prepared soft-shell extract was quantified using liquid chromatography, and it was confirmed that upatilin was 1.6 wt% and zeosidine was 0.68 wt%.
<실시예1-3> 쑥추출물 제조<Example 1-3> Preparation of mugwort extract
황해쑥(Artemisia argyi) 1Kg을 1-프로판올 10Kg에 가하여(중량비 1:10) 추출 후 잔류물에 추가로 1-프로판올을 가하여 재추출 한다. 그 후, 추출액을 여과하여 65도 이하에서 감압농축하여 연조엑스 50g을 제조하였다. 제조한 연조엑스 50g을 취하여 액체크로마토그래피법을 사용하여 정량하여 유파틸린이 1.3중량%, 자세오시딘이 0.48중량%임을 확인하였다. After extraction by adding 1 kg of Artemisia argyi to 10 kg of 1-propanol (weight ratio 1:10), 1-propanol is additionally added to the residue for re-extraction. Then, the extract was filtered and concentrated under reduced pressure at 65 degrees or less to prepare 50 g of soft extract. 50 g of the prepared soft-shell extract was quantified using liquid chromatography, and it was confirmed that upatilin was 1.3 wt% and zeosidine was 0.48 wt%.
<실시예1-4> 쑥추출물 제조<Example 1-4> Preparation of mugwort extract
황해쑥(Artemisia argyi) 1Kg을 2-프로판올 13Kg에 가하여(중량비 1:13) 추출 후 잔류물에 추가로 2-프로판올을 가하여 재추출 한다. 그 후, 추출액을 여과하여 65도 이하에서 감압농축하여 연조엑스 50g을 제조하였다. 제조한 연조엑스 50g을 취하여 액체크로마토그래피법을 사용하여 정량하여 유파틸린이 1.2중량%, 자세오시딘이 0.5중량%임을 확인하였다. 1Kg of Artemisia argyi is added to 13Kg of 2-propanol (weight ratio 1:13), and after extraction, additional 2-propanol is added to the residue for re-extraction. Then, the extract was filtered and concentrated under reduced pressure at 65 degrees or less to prepare 50 g of soft extract. 50 g of the prepared soft algae extract was quantified using liquid chromatography, and it was confirmed that upatilin was 1.2 wt% and zeosidine was 0.5 wt%.
<실시예2> 쑥추출물 혼합물 제조<Example 2> Preparation of mugwort extract mixture
실시예1-2에서 제조된 쑥추출물 1kg을 4kg 소맥말분으로 희석하여 5kg으로 한 후에, 5kg의 소맥말분과 쑥추출물 혼합물을 추가로 65kg의 소맥말분과 30kg의 탄산칼슘을 첨가하여 100kg으로 제조하였다. After diluting 1 kg of the mugwort extract prepared in Example 1-2 with 4 kg wheat flour to 5 kg, a mixture of 5 kg wheat flour and mugwort extract was further added to 65 kg wheat flour and 30 kg calcium carbonate to make 100 kg. .
이렇게 제조한 쑥추출물 혼합물 100kg와 표1의 조성을 갖는 일반동물사료를 혼합하여 최종 쑥추출물을 포함하는 동물사료 200,000kg으로 하여 동물에게 급이하였다. 표1의 조성에서 Vit. mixture은 비타민A 40,000 IU, 비타민D3 8,000 IU, 비타민E 10 IU, 비타민K3 4mg, 비타민B1 4mg, 비타민B2 12mg, 비타민B6 6mg, 비타민B12 20μg, 판토텐산 20mg, 엽산 2mg, 니코틴산 60mg의 혼합물이다. 또한, Mineral mixture은 Fe 30mg, Zn 25mg, Mn 20mg, Co 0.15mg, Cu 5mg, Se 0.1mg을 포함한다. 위의 표1의 조성을 갖는 쑥추출물을 포함하지 않는 일반 동물사료를 비교예1로하여 실시예2와 비교예1을 각각 최대 5주동안 급이하였다. <실험예1> 간독성 및 증체량 시험100 kg of the mugwort extract mixture prepared in this way and the general animal feed having the composition shown in Table 1 were mixed, and the final animal feed containing the mugwort extract was 200,000 kg, and fed to the animals. In the composition of Table 1, Vit. The mixture is a mixture of vitamin A 40,000 IU, vitamin D3 8,000 IU, vitamin E 10 IU, vitamin K3 4 mg, vitamin B1 4 mg, vitamin B2 12 mg, vitamin B6 6 mg, vitamin B12 20 μg, pantothenic acid 20 mg, folic acid 2 mg, nicotinic acid 60 mg. In addition, the mineral mixture contains Fe 30mg, Zn 25mg, Mn 20mg, Co 0.15mg, Cu 5mg, Se 0.1mg. A general animal feed containing no mugwort extract having the composition of Table 1 above was used as Comparative Example 1, and Example 2 and Comparative Example 1 were each fed for up to 5 weeks. <Experimental Example 1> Hepatotoxicity and weight gain test
실시예2와 비교예1의 동물용 사료 혼합물을 이용하여 1일령 육계 병아리를 대상으로 각각 실시예2는 9,000마리, 비교예1은 20,500마리를 이용하여 총 21일간 사양실험을 실시하였다. 이때 kg당 1일 쑥추출물의 복용량은 평균 0.25mg(유파틸린으로서 0.0020mg/kg)이 되도록 조정하였다. Using the animal feed mixture of Example 2 and Comparative Example 1, a feeding experiment was carried out for a total of 21 days using 9,000 birds in Example 2 and 20,500 birds in Comparative Example 1 targeting 1-day-old broiler chicks, respectively. At this time, the daily dose of mugwort extract per kg was adjusted to an average of 0.25 mg (0.0020 mg/kg as eupatylin).
*P-value는 95% 신뢰구간에서 계산되었다.*P-value was calculated at 95% confidence interval.
표3은 쑥 추출물을 급여한 육계 혈장내 간기능 관련 효소 활성 분석 결과이다. 혈액 내의 GOT수준은 가금에 있어서 간 및 조직의 손상정도를 나타내는 지표로 이용될 수 있으며, 사료 내 새로운 대체원료나 기능성 첨가제 도입시 안전성을 검증하는 지표가 될 수 있다. 따라서, 표3의 결과를 통해서 쑥 추출물의 첨가급여가 육계에 부정적인 영향을 끼치지 않는 것을 확인할 수 있었다. Table 3 shows the results of analysis of liver function-related enzyme activity in broiler plasma fed with mugwort extract. The level of GOT in the blood can be used as an indicator to indicate the degree of damage to the liver and tissues in poultry, and can be an indicator to verify the safety when introducing a new alternative raw material or functional additive in the feed. Therefore, through the results in Table 3, it was confirmed that the supplementary feeding of mugwort extract did not have a negative effect on broilers.
표4의 쑥 추출물을 급여한 육계의 증체량을 측정한 결과이다. 비교예1에 비해서 실시예2의 증체량이 더 높은 결과를 갖는 것을 확인할 수 있었다. <실험예2> 생산성 비교Table 4 shows the results of measuring the weight gain of broilers fed with mugwort extract. It was confirmed that the weight gain of Example 2 was higher than that of Comparative Example 1. <Experimental Example 2> Productivity comparison
육계 병아리 85,000수를 비교예1은 38,000마리, 실시예2는 53,000마리로 각각 비교하고자 하였으며 총 33일 간 사양실험을 진행 후 급여를 통한 생산성을 조사하였다. 이때 kg당 1일 쑥추출물의 복욕량은 평균 0.26mg(유파틸린으로서 0.0021mg/kg)이 되도록 조정하였다.The number of 85,000 broiler chicks was compared to 38,000 in Comparative Example 1 and 53,000 in Example 2, respectively, and the productivity through feeding was investigated after a breeding experiment for a total of 33 days. At this time, the daily bathing amount of mugwort extract per kg was adjusted to an average of 0.26 mg (0.0021 mg/kg as eupatylin).
표5의 경우, 육계 생산성에 있어서 쑥 추출물이 미치는 영향을 나타내었다. 쑥 추출물을 포함한 실시예2의 경우 폐사율면에서 쑥추출물을 포함시키지 않은 비교예1에 비해서 약 95%이상 개선되는 결과를 보였으며 평균체중도 증가되었다. 또한, 객관적인 상대지표를 나타내는 생산지수에서 실시예2의 경우 비교예1에 비해서 약 8% 증가한 결과를 나타내는 것을 볼 수 있었다. 이상의 결과들을 바탕으로 했을 때, kg당 0.26mg의 쑥추출물만으로 동물의 폐사율개선, 평균체중증가 및 생산지수를 극대화 시킬 수 있었으며 이러한 결과들을 바탕으로 소량의 쑥추출물을 포함한 동물사료가 항생제 사용 규제의 대체물로서 이용되어 농가의 소득향상에 기여할 수 있음을 확인하였다.Table 5 shows the effect of mugwort extract on broiler productivity. In the case of Example 2 including the mugwort extract, the mortality rate was improved by about 95% or more compared to Comparative Example 1 without the mugwort extract, and the average body weight was also increased. In addition, in the case of Example 2 in the production index representing an objective relative indicator, it was seen that the result was increased by about 8% compared to Comparative Example 1. Based on the above results, only 0.26 mg of mugwort extract per kg could improve animal mortality, increase average weight, and maximize production index. It was confirmed that it can be used as a substitute and can contribute to the improvement of farm households' income.
Claims (11)
상기 쑥 추출물은 1-프로판올 또는 2-프로판올을 쑥 중량 대비 10배 이상 첨가하여 추출 후, 잔류물에 추가로 1-프로판올 또는 2-프로판올을 가하여 재추출하는 단계; 및
상기 재추출하여 얻어진 추출액을 여과하여 감압농축하여 연조엑스 형태의 쑥 추출물을 제조하는 단계에 의해 제조된 것이고,
상기 제조된 쑥 추출물에는 유파틸린 0.8~2.4 중량% 및 자세오시딘 0.25~0.75 중량%를 포함하는 것이며,
상기 동물사료는 옥수수 (Yellow corn), 소맥(Wheat), 대두박 (Soybean meal), 옥수수글루텐박 (Corn gluten meal), 우지 (Tallow), 리신염산염(LysineHCl), 제2인산칼슘 (Dicalcium phosphate), DL-메티오닌 (DL-methionine), 석회석 (Limestone), 염화콜린 (Choline chloride), 소금 (Salt), 비타민 혼합물 (Vit. mixture) 및 미네랄 혼합물 (Min. mixture)를 포함하는 것을 특징으로 하는 사료조성물의 제조방법.
It is prepared by mixing the soft seaweed extract obtained including the process of filtering and concentrating the mugwort extract, and the mugwort extract mixture mixed with wheat flour and calcium carbonate, and animal feed,
The mugwort extract is extracted by adding 1-propanol or 2-propanol at least 10 times the weight of mugwort, followed by re-extraction by adding 1-propanol or 2-propanol to the residue; and
It is prepared by filtering the extract obtained by the re-extraction and concentrating under reduced pressure to prepare a mugwort extract in the form of soft algae extract,
The prepared mugwort extract contains 0.8 to 2.4% by weight of eupatylin and 0.25 to 0.75% by weight of zagiosidine,
The animal feed is corn (Yellow corn), wheat (Wheat), soybean meal (Soybean meal), corn gluten meal (Corn gluten meal), tallow (Tallow), lysine hydrochloride (LysineHCl), dibasic calcium phosphate (Dicalcium phosphate), DL-methionine (DL-methionine), limestone (Limestone), choline chloride (Choline chloride), salt (Salt), a vitamin mixture (Vit. mixture) and a feed composition comprising a mineral mixture (Min. mixture) manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190072885A KR102258773B1 (en) | 2011-07-26 | 2019-06-19 | An animal feed form with poultry productivity improvement |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110074204A KR20110102260A (en) | 2011-07-26 | 2011-07-26 | An animal feed form with poultry productivity improvement |
KR1020190072885A KR102258773B1 (en) | 2011-07-26 | 2019-06-19 | An animal feed form with poultry productivity improvement |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110074204A Division KR20110102260A (en) | 2011-07-26 | 2011-07-26 | An animal feed form with poultry productivity improvement |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190075872A KR20190075872A (en) | 2019-07-01 |
KR102258773B1 true KR102258773B1 (en) | 2021-06-01 |
Family
ID=67255373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190072885A KR102258773B1 (en) | 2011-07-26 | 2019-06-19 | An animal feed form with poultry productivity improvement |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102258773B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003292444A (en) | 2002-02-04 | 2003-10-15 | Kyowa Hakko Kogyo Co Ltd | Insulin secretion promoting agent |
KR100414453B1 (en) * | 1996-07-12 | 2004-04-03 | 동아제약 주식회사 | Artemisia asiatica extract as agent for treatment of inflammatory bowel disease |
KR100528313B1 (en) * | 2004-07-14 | 2005-11-15 | 알앤엘생명과학주식회사 | Composition for promoting growth of animal comprising extracts of artemisia capillaris thunberg., acanthopanax and garlic and feed composition for promoting growth comprising the composition |
WO2006004358A1 (en) | 2004-07-03 | 2006-01-12 | Dong-A Pharm. Co., Ltd. | Dicoumarol-removed extract of artemisia, preparation and pharmaceutical compositions thereof |
KR100861456B1 (en) * | 2007-08-23 | 2008-10-02 | 안종만 | Feed additive of a wild plant and how to make it |
WO2009038340A1 (en) | 2007-09-21 | 2009-03-26 | Dong-A Pharm.Co., Ltd. | Pharmaceutical composition of artemisia extract using gastro-retentive drug delivery system and its oral sustained release formulation |
KR100900725B1 (en) * | 2008-02-14 | 2009-06-05 | 지엘팜텍 주식회사 | A preparation method of artemisia extract containing high content of eupatilin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2004091642A1 (en) * | 2003-04-11 | 2006-07-06 | 協和醗酵工業株式会社 | Preventive or therapeutic agent for arthritis |
KR20090066858A (en) * | 2007-12-20 | 2009-06-24 | 강화군 | Pharmaceutical composition for treating and preventing diabetes |
KR101080648B1 (en) * | 2009-02-26 | 2011-11-09 | 서울대학교산학협력단 | A method for isolating and producing highly-concentrated Eupatilin and Jaceosidine from the extract of Artemisia species by using Centrifugal Partition Chromatography |
KR101087269B1 (en) * | 2009-04-07 | 2011-11-29 | 농업회사법인조인주식회사 | Process for producing feedstuff additives with a bacteria inhibiting activity comprising fermented wormwoods and process for obtaining eggs using the said feedsutff |
KR101578982B1 (en) * | 2013-12-31 | 2015-12-29 | 단국대학교 천안캠퍼스 산학협력단 | A feed additive for poultry comprising Yucca schidigera extract and carbohydrase as an effective ingredient, a feed composition and a breeding method using the same |
-
2019
- 2019-06-19 KR KR1020190072885A patent/KR102258773B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100414453B1 (en) * | 1996-07-12 | 2004-04-03 | 동아제약 주식회사 | Artemisia asiatica extract as agent for treatment of inflammatory bowel disease |
JP2003292444A (en) | 2002-02-04 | 2003-10-15 | Kyowa Hakko Kogyo Co Ltd | Insulin secretion promoting agent |
WO2006004358A1 (en) | 2004-07-03 | 2006-01-12 | Dong-A Pharm. Co., Ltd. | Dicoumarol-removed extract of artemisia, preparation and pharmaceutical compositions thereof |
KR100528313B1 (en) * | 2004-07-14 | 2005-11-15 | 알앤엘생명과학주식회사 | Composition for promoting growth of animal comprising extracts of artemisia capillaris thunberg., acanthopanax and garlic and feed composition for promoting growth comprising the composition |
KR100861456B1 (en) * | 2007-08-23 | 2008-10-02 | 안종만 | Feed additive of a wild plant and how to make it |
WO2009038340A1 (en) | 2007-09-21 | 2009-03-26 | Dong-A Pharm.Co., Ltd. | Pharmaceutical composition of artemisia extract using gastro-retentive drug delivery system and its oral sustained release formulation |
KR100900725B1 (en) * | 2008-02-14 | 2009-06-05 | 지엘팜텍 주식회사 | A preparation method of artemisia extract containing high content of eupatilin |
Also Published As
Publication number | Publication date |
---|---|
KR20190075872A (en) | 2019-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103549222B (en) | Compound feed additive for preventing piglet diarrhea and preparation method thereof | |
CN102132764A (en) | Application of para-thymol, salts ramification thereof or esters ramification thereof in animal feed additive | |
CN110692863A (en) | Plant extract feed additive for improving liver and intestine protecting capability of tilapia | |
CN109512999A (en) | The application of synergetic effect additive of the fatty alcohol of oxygen-containing hydrocarbon derivative as polymyxins | |
CN111011602A (en) | Functional feed additive for relieving oxidative stress of livestock and poultry and improving intestinal health and preparation method thereof | |
CN1957742A (en) | Compound feedstuff additive superfines of Chinese traditional medicine, and preparation method | |
OKEY | Alternative feed additives to antibiotics in improving health and performance in poultry and for the prevention of antimicrobials: a review | |
CN117322559A (en) | Disease-resistant growth-promoting feed additive for sea fish and preparation method thereof | |
KR102258773B1 (en) | An animal feed form with poultry productivity improvement | |
CN111184138A (en) | Antibiotic-free and zinc oxide-free livestock feed and application thereof | |
CN113397041A (en) | Application of flood dragon wood in livestock breeding | |
KR101032033B1 (en) | Antimicrobial composition comprising medium chain fatty acids for addition to feedstuff, process thereof and feedstuff comprising the same | |
CN113057261A (en) | Acid preparation composition for improving production performance of meat pigeons, preparation method and application | |
KR20110102260A (en) | An animal feed form with poultry productivity improvement | |
CN102247390B (en) | Medicine for treating bacterial air sacculitis in livestock and preparation method thereof | |
CN112586627A (en) | Disease-resistant growth-promoting green feed additive for poultry and preparation method thereof | |
KR101273276B1 (en) | Method for producing feed for livestock adding curcumin and feed for livestock produced by the same | |
KR20200058353A (en) | Antimicrobial composition comprising the hexane and butanol fractions of teleogryllus emma extract | |
CN113261623A (en) | Mixed feed additive for replacing antibiotics in broiler feed and broiler feed | |
KR102321162B1 (en) | A feed supplement composition for reducing zinc oxide of feed comprising Phellodendron Cortex extract as an effective ingredient | |
CN111587953B (en) | Traditional Chinese medicine compound feed additive for replacing antibiotics and preparation method and application thereof | |
KR20170062962A (en) | Composition of feed additive with probiotics | |
KR102026529B1 (en) | Natural feed additive composition for prevention and therapy of Myxozoa infection | |
CN106983771B (en) | Medicine and composition for preventing and treating hippocampus head ulceration | |
CN117179151A (en) | Feed additive mixture for replacing antibiotics by combined application of brassin and oligosaccharin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |